National Institute for Medical Research

What National Institute for Medical Research does

The National Institute for Medical Research (NIMR) is the statutory health research body of the United Republic of Tanzania, established by Act of Parliament No. 23 of 1979 and operational since 1980 under the Ministry of Health. Operating as both the technical arm of the Ministry and the national regulator of health research, NIMR conducts, coordinates, registers, monitors, evaluates and promotes all health research conducted in Tanzania. The institute runs seven specialized research centres — Amani, Tanga, Muhimbili, Mwanza, Mbeya, Mabibo (Traditional Medicine) and Dodoma — supported by seven research stations and a workforce of more than 260 researchers.

NIMR's service portfolio spans accredited laboratory testing (SANAS-GLP vector-control evaluation, SADCAS ISO 15189 TB reference services, CAP/SADQAS immunology and TB labs at Mbeya, BSL-1 to BSL-3 containment), clinical trial execution (phase I/II HIV vaccine trials, TB drug and vaccine trials, multi-centre trials via REDAMS), molecular and genomic diagnostics (Oxford Nanopore sequencing, PCR, HPLC, ELISA, flow cytometry), vector biology and insecticide-resistance surveillance across 32 sentinel sites, traditional-medicine evaluation, and policy-translation deliverables to national disease-control programs. Internal data infrastructure includes OpenClinica (FDA 21 CFR Part 11-compliant), CSPro and the proprietary REDAMS platform.

The institute is funded through a combination of Tanzanian government allocation and a diversified portfolio of international research grants from the Bill and Melinda Gates Foundation, EDCTP, NIH, USAID/PMI, Global Fund, World Bank, UNICEF, NIHR and others. End-customers are almost exclusively public-sector: the Ministry of Health, vertical disease programs (NTLP, NACP, NMCP, NTD Programme), regional referral hospitals, and global health partners such as WHO and IVCC. Research output exceeds 4,000 peer-reviewed publications, and outputs have demonstrably shaped WHO guidelines and Tanzania's national treatment policies for HIV, TB and malaria.

Name

National Institute for Medical Research

Legal name

National Institute for Medical Research

Website

https://nimr.or.tz

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

501–1,000 employees

Short description

NIMR is Tanzania's statutory government medical research institute, operating seven specialized research centres as the technical arm of the Ministry of Health. It conducts clinical trials, accredited laboratory testing, disease surveillance, and policy-formulation research for national health programs and international partners.

Ownership category

akta.pro rank

Product category

Public Health Research Services

NAICS

Scientific Research and Development Services (5417), Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (62151)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)

akta.pro industry

PRIMARYHLAJADAF

Clinical Trials Authorization & Oversight (GCP)

Healthcare & Life Sciences/Public Health, Government & Regulators/Medicines & Healthcare Product Regulators (Drugs/Biologics/Devices)

SECONDARYHLAGACAF

Investigator & Site Training / GCP Support

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLAGAKAK

Laboratory Quality & GLP/GCLP Compliance

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

SECONDARYHLAGAEAF

Microbiology & Infectious Disease Testing (Trial Support)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

SECONDARYBPAIAJAI

Non-Communicable Disease Prevention & Chronic Disease Programs

Business & Public Services/Public Sector & Government Administration/Public Health Administration & Regulation

SECONDARYHLAJAKAF

Disease-Specific Global Programs (HIV/TB/Malaria/NTDs)

Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)

Keywords

• Public health research
• Clinical trial services
• Laboratory testing services
• Vector control research
• Health policy advisory

Headquarters

HQ city

Dar Es Salaam

HQ country

Tanzania

HQ region

Africa

Offices9 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Technology or R&D, Supply Chain

Revenue model

1. Government Funding: NIMR receives core funding from the Tanzanian Government through the Ministry of Health as the technical arm of the ministry responsible for health.
2. International Research Grants: Active funding from EDCTP, EU, NIHR, World Bank, UNICEF, USAID (through Engender Health organisation), Global Fund, and National Institute of Health. Multiple ongoing research projects funded by these international agencies.
3. Bill and Melinda Gates Foundation: Support for AMBRELA laboratory construction and PATH-Malaria Vaccine Initiative funding for Korogwe Research Laboratory construction.
4. PMI/USAID Partnership: Partnership with US President's Malaria Initiative for insecticide resistance monitoring and generation of resistance data across the country.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

The National Institute for Medical Research (NIMR) is Tanzania's statutory government medical research institute mandated to conduct, control, coordinate, register, monitor, evaluate, and promote health research. Through seven specialized research centres and seven research stations, NIMR delivers GCLP-compliant laboratory testing services, accredited clinical trial execution (HIV, TB, malaria, COVID-19 vaccines), vector control product evaluation under OECD GLP, disease surveillance for national control programs, traditional medicine research, and evidence-based policy support to the Ministry of Health and international partners.

Product overview

The National Institute for Medical Research (NIMR) is Tanzania's principal government medical research organization operating through seven specialized research centres (Amani, Mbeya, Muhimbili, Mwanza, Tanga, Mabibo, Dodoma) and seven research stations. Rather than a unified software product, NIMR offers a portfolio of research services including: laboratory testing services (GCLP-compliant diagnostics, TB reference testing, malacology); clinical trial services (HIV vaccine trials, TB drug trials, vaccine trials); data management services (OpenClinica, CSPro, REDAMS); vector control product evaluation (GLP-accredited); traditional medicine research; and the AJSC conference platform for annual scientific conference coordination. The AJSC 2026 platform enables abstract submission, peer review, registration, and certificate management for the Annual Joint Scientific Conference.

Differentiator

Problem solved

Functional benefit

Products and services

• Schistosomiasis and Soil-Transmitted Helminth (STH) Research Services Specialized parasitological diagnosis (Kato Katz, formal ether concentration, FLOTAC), molecular techniques (PCR), malacology research, and snail control training services delivered by NIMR Mwanza Centre for researchers and public health programs targeting schistosomiasis and STH.
• TB/HIV Clinical Trial Services Clinical research services for multi-centre HIV and TB trials, cryptococcal meningitis treatment studies, and advanced HIV disease management trials conducted at NIMR Muhimbili Centre's BSL-3 laboratory, serving international sponsors, research networks, and the Ministry of Health.
• HIV Vaccine Trial Services Phase I/II HIV vaccine trial capabilities with CAP-accredited laboratory at NIMR Mbeya Centre, with a track record of 8 HIV vaccine trials, over 10 TB drug trials, and 2 TB vaccine trials for international sponsors and trial networks.
• Malacology Laboratory Services Specialized malacology laboratory services for snail research including morphological identification, cercariae shedding experiments, molecular snail and schistosome characterization, and snail control training at NIMR Mwanza Centre (BSL-2 designated).
• Central TB Reference Laboratory Services ISO 15189 accredited tuberculosis reference laboratory offering AFB smear microscopy, GeneXpert MTB/RIF Ultra testing, conventional mycobacterial culture, and Line Probe Assay services through NIMR Muhimbili Centre, recognized by Tanzania Ministry of Health and WHO.
• Clinical Data Management Services Electronic and physical data capture, management, and analysis services using CSPro and OpenClinica platforms (FDA 21 CFR Part 11a GCP-compliant) with trained staff experienced in PDA, tablet, and smartphone data collection at NIMR Mwanza Centre.
• Vector Control Tool Evaluation Services OECD GLP accredited (SANAS) testing services for evaluation of insecticides, insecticide-treated fabrics, long-lasting insecticidal nets (LLINs), indoor residual spraying (IRS) products, larvicides, and other vector control tools for malaria and vector-borne disease control, delivered by NIMR Amani Centre.
• Traditional Medicine Research Services Pre-clinical and clinical evaluation of medicinal plants for efficacy and toxicity, extraction and isolation of active compounds, product formulation, and herbal medicine production at NIMR Mabibo Traditional Medicine Centre, serving traditional medicine practitioners, researchers, and regulators.
• AJSC Conference Platform Web-based platform for the Annual Joint Scientific Conference enabling abstract submission, delegate registration, peer review management, certificate issuance, and event coordination for NIMR's annual scientific conference (33rd AJSC 2026 held June 9-11 at AICC Arusha).

Quantifiable outcome

• Contributed to WHO Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy, reducing mortality by 30%
• +5 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• World Health Organization (WHO)coreStrategic or Co-development PartnerLong-term partner of WHO WHOPES and WHO PQT-VC for evaluation of public health pesticides; contributes data to WHO guidelines; recognized as WHO reference centre for vector control trials.
• Innovative Vector Control Consortium (IVCC)coreStrategic or Co-development PartnerCollaboration on research and development of public health insecticides and vector control products for malaria control.
• London School of Tropical Medicine and HygienecoreStrategic or Co-development PartnerCollaborative research providing evidence on ITN effectiveness in reducing malaria; joint publications in peer-reviewed journals.
• Institute of Tropical Medicine, AntwerpminorStrategic or Co-development PartnerInternational research collaboration for TB and infectious disease research.
• Muhimbili University of Health and Allied Sciences (MUHAS)coreStrategic or Co-development PartnerAcademic partnership for research collaboration, mentorship, training internship supervision and dissemination of research findings.
• Ifakara Health Institute (IHI)coreStrategic or Co-development PartnerNational research institution partnership for implementation research and health systems strengthening in Tanzania.
• Sokoine University of Agriculture (SUA)coreStrategic or Co-development PartnerAgricultural and veterinary research collaboration supporting One Health initiatives and zoonotic disease research.
• Zanzibar Health Research Institute (ZAHRI)minorStrategic or Co-development PartnerPartnership for health research coordination between mainland Tanzania and Zanzibar.

Scale indicators8 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• MRC/UVRI & LSHTM Uganda Research Unit: Uganda-based Medical Research Council unit conducting HIV, TB, Ebola, and NCD clinical trials with strong GCP-compliant lab infrastructure; a regional peer with comparable multi-disease trial portfolio serving East African populations.
• Ifakara Health Institute: Tanzania's other leading public health research institute, focused on implementation research, malaria entomology, and demographic surveillance; comparable to NIMR as a domestic peer competing for similar government and donor-funded mandates, although narrower in regulatory authority.
• Kenya Medical Research Institute (KEMRI): Kenya's statutory government medical research body operating multiple research centres with GCLP labs, clinical trial capacity, and a mandate to coordinate health research nationally—the closest structural analogue to NIMR in East Africa.
• South African Medical Research Council (SAMRC): South Africa's statutory medical research council funding and coordinating health research across multiple intramural and extramural units; comparable as a larger, well-resourced African government medical research peer to NIMR.
• Noguchi Memorial Institute for Medical Research: Ghana's premier government biomedical research institute with BSL-3 labs, clinical trial capability, and a national infectious-disease surveillance mandate; a directly comparable West African peer for African biomedical research capacity.
• Malawi-Liverpool-Wellcome Trust Clinical Research Programme (MLW): Malawi-based clinical research programme with BSL-3 labs and GCP-compliant clinical trial capacity serving East/Southern Africa; comparable peer for HIV/TB/severe infectious disease trials and surveillance.

Broad incumbents

• Centers for Disease Control and Prevention (CDC) Kenya / Global Health Division: The CDC's Global Health Division funds and co-operates HIV/TB/malaria labs and surveillance in PEPFAR countries including Tanzania; a broader incumbent funder-operator whose field labs overlap directly with NIMR's programme scope.
• European and Developing Countries Clinical Trials Partnership (EDCTP): Major funder of NIMR's clinical research and a pan-African clinical trials coordination body overseeing 400+ projects; an incumbent convening organisation whose portfolio directly overlaps and amplifies NIMR's regional trial work.

Emerging players

• PATH Malaria Vaccine Initiative: Global health non-profit that funded NIMR's Korogwe Research Laboratory; comparable as a partner-developer advancing malaria vaccine evaluation that channels trials into NIMR sites.
• Innovative Vector Control Consortium (IVCC): Product Development Partnership that co-develops new vector control insecticides with NIMR Amani Centre; comparable as an adjacent R&D partner dependent on NIMR's GLP testing infrastructure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/nimr_tanzania
• YouTubeyoutube.com/@nimr_tanzania
• Facebookfacebook.com/NIMRHQ.Tanzania
• Instagraminstagram.com/nimr.tanzania
• LinkedInlinkedin.com/company/national-institute-for-medical-research-tanzania

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Institute for Medical Research